HK1171082A1 - 基於 基因型的癌診斷與治療 - Google Patents
基於 基因型的癌診斷與治療Info
- Publication number
- HK1171082A1 HK1171082A1 HK12111787.0A HK12111787A HK1171082A1 HK 1171082 A1 HK1171082 A1 HK 1171082A1 HK 12111787 A HK12111787 A HK 12111787A HK 1171082 A1 HK1171082 A1 HK 1171082A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- odci
- odc1
- genotype
- treatments
- carcinoma diagnosis
- Prior art date
Links
- 201000009030 Carcinoma Diseases 0.000 title 1
- 101100277160 Xenopus laevis odc1-a gene Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21621609P | 2009-05-14 | 2009-05-14 | |
US21767909P | 2009-06-03 | 2009-06-03 | |
US21768209P | 2009-06-03 | 2009-06-03 | |
PCT/US2010/034974 WO2010132817A1 (en) | 2009-05-14 | 2010-05-14 | Carcinoma diagnosis and treatments, based on odc1 genotype |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1171082A1 true HK1171082A1 (zh) | 2013-03-15 |
Family
ID=43085356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12111787.0A HK1171082A1 (zh) | 2009-05-14 | 2012-11-19 | 基於 基因型的癌診斷與治療 |
Country Status (16)
Country | Link |
---|---|
US (4) | US8329636B2 (zh) |
EP (1) | EP2430452B1 (zh) |
JP (2) | JP6083860B2 (zh) |
CN (1) | CN102483415B (zh) |
AU (1) | AU2010248803B2 (zh) |
CA (1) | CA2761946A1 (zh) |
DK (1) | DK2430452T3 (zh) |
ES (1) | ES2507145T3 (zh) |
HK (1) | HK1171082A1 (zh) |
HR (1) | HRP20140887T1 (zh) |
IL (1) | IL216369B (zh) |
PL (1) | PL2430452T3 (zh) |
PT (1) | PT2430452E (zh) |
SI (1) | SI2430452T1 (zh) |
SM (1) | SMT201400177B (zh) |
WO (1) | WO2010132817A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8329636B2 (en) | 2009-05-14 | 2012-12-11 | Arizona Board Of Regents On Behalf Of University Of Arizona | Carcinoma diagnosis and treatment, based on ODC1 genotype |
EP2568978B1 (en) * | 2010-05-14 | 2019-04-24 | Arizona Board of Regents on Behalf of University of Arizona | Cancer prevention and treatment based on dietary polyamine content |
US20120172244A1 (en) | 2010-12-20 | 2012-07-05 | Steven Buechler | Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease |
WO2012088146A2 (en) * | 2010-12-20 | 2012-06-28 | The University Of Notre Dame | Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease |
EP2912193B1 (en) | 2012-10-29 | 2018-08-29 | Arizona Board of Regents on Behalf of University of Arizona | Predictive markers for polyamine inhibitor cancer therapies |
US10655183B2 (en) | 2014-06-18 | 2020-05-19 | Arizona Board Of Regents On Behalf Of University Of Arizona | Carcinoma diagnosis and treatment based on ODC1 genotype |
US20190046484A1 (en) * | 2015-02-12 | 2019-02-14 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating neuroblastoma |
JP2018513508A (ja) * | 2015-03-16 | 2018-05-24 | パーソナル ジノーム ダイアグノスティクス, インコーポレイテッド | 核酸を分析するためのシステムおよび方法 |
KR20180069068A (ko) | 2015-10-30 | 2018-06-22 | 캔서 프리벤션 파마수티컬스, 인코포레이티드 | 에플로르니틴 및 설린닥, 고정된 용량 조합 제제 |
WO2017075576A1 (en) | 2015-10-30 | 2017-05-04 | Cancer Prevention Pharmaceuticals, Inc. | Eflornithine and sulindac, fixed dose combination formulation |
JP6963271B2 (ja) * | 2017-01-20 | 2021-11-05 | 国立大学法人東海国立大学機構 | イヌの遺伝性消化管腫瘍症の遺伝子診断法 |
JP2022532766A (ja) | 2019-05-17 | 2022-07-19 | キャンサー プリベンション ファーマシューティカルズ,インコーポレイテッド | 家族性腺腫性ポリポーシスを処置するための方法 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3647858A (en) | 1970-05-01 | 1972-03-07 | Merck & Co Inc | Process for preparing 1-benzylidene-3-indenyl acetic acids |
US3654349A (en) | 1970-05-01 | 1972-04-04 | Merck & Co Inc | Substituted indenyl acetic acids |
US4330559A (en) | 1977-07-11 | 1982-05-18 | Merrell-Toraude Et Cie | Method of treating benign prostatic hypertrophy |
US4413141A (en) | 1977-07-11 | 1983-11-01 | Merrell Toraude Et Compagnie | 2-(Difluoromethyl)-2,5-diaminopentanoic acid |
BR8108820A (pt) | 1980-09-24 | 1982-08-24 | Cetus Corp | Processo e sonda de diagnostico |
DE3381518D1 (de) | 1982-01-22 | 1990-06-07 | Cetus Corp | Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel. |
GB8311018D0 (en) | 1983-04-22 | 1983-05-25 | Amersham Int Plc | Detecting mutations in dna |
US4683194A (en) | 1984-05-29 | 1987-07-28 | Cetus Corporation | Method for detection of polymorphic restriction sites and nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4859452A (en) | 1986-01-17 | 1989-08-22 | Board Of Regents, The University Of Texas System | Methods for the reduction of difluoromethylornithine associated toxicity |
CA1284931C (en) | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
US4925835A (en) | 1986-05-01 | 1990-05-15 | Sloan-Kettering Institute For Cancer Research | Aziridinyl putrescine containing compositions and their uses in treating prostate cancer |
US5002879A (en) | 1986-05-06 | 1991-03-26 | Merrell Dow Pharmaceuticals | Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor |
CA1338457C (en) | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
FR2650840B1 (fr) | 1989-08-11 | 1991-11-29 | Bertin & Cie | Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications |
US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
FR2706255B1 (fr) | 1993-06-17 | 1995-10-27 | Univ Rennes | Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques. |
EP0754240B1 (en) | 1994-02-07 | 2003-08-20 | Beckman Coulter, Inc. | Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis |
US5843929A (en) | 1996-03-22 | 1998-12-01 | Mayo Foundation For Medical Education And Research | Chemoprevention of metachronous adenomatous colorectal polyps |
AU754864B2 (en) * | 1998-03-28 | 2002-11-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona, The | DFMO and sulindac combination in cancer chemoprevention |
US7700568B2 (en) * | 1998-06-30 | 2010-04-20 | Sloan-Kettering Institute For Cancer Research | Uses of DNA-PK |
JP2002533387A (ja) * | 1998-12-23 | 2002-10-08 | ジー.ディー.サール & カンパニー | 腫瘍治療の複合療法としてインテグリン拮抗物質と一つ以上の抗腫瘍剤を使用する方法 |
US6753422B2 (en) | 1999-03-01 | 2004-06-22 | O'brien Thomas G. | Odc allelic analysis method for assessing carcinogenic susceptibility |
EP1178795A1 (en) | 1999-05-17 | 2002-02-13 | Ilex Oncology, Inc. | Dfmo and celecoxib in combination for cancer chemoprevention and therapy |
US6602910B2 (en) | 2000-03-07 | 2003-08-05 | Ilex Oncology, Inc. | D-enantiomer of DFMO and methods of use therefor |
WO2001068076A2 (en) | 2000-03-07 | 2001-09-20 | Ilex Oncology, Inc. | D-enantiomer of dfmo and methods of use thereof for treating cancer |
WO2002015895A2 (en) | 2000-08-24 | 2002-02-28 | The Regents Of The University Of California | Alpha-difluoromethylornithine (dfmo) use in the human prostate |
US7030126B2 (en) | 2001-11-16 | 2006-04-18 | Als Therapy Development Foundation, Inc. | Use of polyamine analogs for amyotrophic lateral sclerosis |
WO2007075673A1 (en) | 2005-12-20 | 2007-07-05 | University Of Hawaii | Treatment regimen for n-myc, c-myc, and l-myc amplified and overexpressed tumors |
WO2009048932A2 (en) | 2007-10-09 | 2009-04-16 | Children's Medical Center Corporation | Methods to regulate mirna processing by targeting lin-28 |
WO2010077653A2 (en) | 2008-12-08 | 2010-07-08 | The Procter & Gamble Company | Personal care composition in the form of an article having a hydrophobic surface-resident coating |
US8329636B2 (en) | 2009-05-14 | 2012-12-11 | Arizona Board Of Regents On Behalf Of University Of Arizona | Carcinoma diagnosis and treatment, based on ODC1 genotype |
EP2568978B1 (en) | 2010-05-14 | 2019-04-24 | Arizona Board of Regents on Behalf of University of Arizona | Cancer prevention and treatment based on dietary polyamine content |
EP2912193B1 (en) | 2012-10-29 | 2018-08-29 | Arizona Board of Regents on Behalf of University of Arizona | Predictive markers for polyamine inhibitor cancer therapies |
-
2010
- 2010-05-14 US US12/780,592 patent/US8329636B2/en active Active
- 2010-05-14 PT PT107756264T patent/PT2430452E/pt unknown
- 2010-05-14 ES ES10775626.4T patent/ES2507145T3/es active Active
- 2010-05-14 PL PL10775626T patent/PL2430452T3/pl unknown
- 2010-05-14 EP EP10775626.4A patent/EP2430452B1/en active Active
- 2010-05-14 CA CA2761946A patent/CA2761946A1/en not_active Abandoned
- 2010-05-14 CN CN201080031983.5A patent/CN102483415B/zh not_active Expired - Fee Related
- 2010-05-14 SI SI201030738T patent/SI2430452T1/sl unknown
- 2010-05-14 AU AU2010248803A patent/AU2010248803B2/en not_active Ceased
- 2010-05-14 DK DK10775626.4T patent/DK2430452T3/da active
- 2010-05-14 JP JP2012511052A patent/JP6083860B2/ja not_active Expired - Fee Related
- 2010-05-14 WO PCT/US2010/034974 patent/WO2010132817A1/en active Application Filing
-
2011
- 2011-11-14 IL IL216369A patent/IL216369B/en active IP Right Grant
-
2012
- 2012-11-19 HK HK12111787.0A patent/HK1171082A1/zh not_active IP Right Cessation
- 2012-12-10 US US13/709,753 patent/US9121852B2/en active Active
-
2014
- 2014-09-17 HR HRP20140887AT patent/HRP20140887T1/hr unknown
- 2014-11-21 SM SM201400177T patent/SMT201400177B/xx unknown
-
2015
- 2015-09-01 US US14/841,750 patent/US9937141B2/en active Active
- 2015-10-29 JP JP2015213116A patent/JP2016074672A/ja active Pending
-
2018
- 2018-02-23 US US15/904,153 patent/US20190038584A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN102483415A (zh) | 2012-05-30 |
EP2430452A4 (en) | 2013-03-06 |
ES2507145T3 (es) | 2014-10-14 |
DK2430452T3 (da) | 2014-10-06 |
US20130164751A1 (en) | 2013-06-27 |
JP6083860B2 (ja) | 2017-02-22 |
US9121852B2 (en) | 2015-09-01 |
US20190038584A1 (en) | 2019-02-07 |
JP2016074672A (ja) | 2016-05-12 |
IL216369B (en) | 2018-07-31 |
US20160213634A1 (en) | 2016-07-28 |
US9937141B2 (en) | 2018-04-10 |
HRP20140887T1 (hr) | 2014-11-21 |
US20100317708A1 (en) | 2010-12-16 |
PT2430452E (pt) | 2014-09-30 |
IL216369A0 (en) | 2012-01-31 |
AU2010248803B2 (en) | 2014-05-29 |
US8329636B2 (en) | 2012-12-11 |
WO2010132817A1 (en) | 2010-11-18 |
AU2010248803A1 (en) | 2011-12-01 |
CN102483415B (zh) | 2015-09-09 |
PL2430452T3 (pl) | 2014-12-31 |
JP2012526852A (ja) | 2012-11-01 |
EP2430452B1 (en) | 2014-06-25 |
EP2430452A1 (en) | 2012-03-21 |
SI2430452T1 (sl) | 2014-11-28 |
SMT201400177B (it) | 2015-01-15 |
CA2761946A1 (en) | 2010-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1171082A1 (zh) | 基於 基因型的癌診斷與治療 | |
EP2539470A4 (en) | METHODS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES | |
EP2179037A4 (en) | DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES | |
AP2011005821A0 (en) | Processing biomas. | |
AP2011005754A0 (en) | Processing biomas. | |
BRPI0814889A2 (pt) | tratamento com ligantes alfa7-seletivos. | |
AP2012006145A0 (en) | Device for turbulence reduction. | |
PL2470517T3 (pl) | Estry kwasu 2,5-furanodikarboksylowego z izometrycznymi dekanolami i ich zastosowanie | |
GB0917044D0 (en) | Agents, uses and methods | |
GB0917054D0 (en) | Agents, uses and methods | |
AP00409S1 (en) | Multidose Inhaler. | |
IT1398947B1 (it) | Struttura di copertura apribile per pergole, verande e simili. | |
BRPI1011093A2 (pt) | corpo de broca, e, broca alinhável. | |
AP00226S1 (en) | Impeller. | |
GB0922085D0 (en) | Cancer diagnosis and treatment | |
GB2477477A9 (en) | Hob. | |
EP2391898A4 (en) | CAPACITANCE VOLTAGE INTERFACE CIRCUIT AND RELATED OPERATING METHODS | |
EP2148272A4 (en) | CALCULATION UNIT, PROCESSOR AND PROCESSOR ARCHITECTURE | |
AP2011005599A0 (en) | Reconstituted rice kernels and processes for theirpreparation. | |
EP2561794A4 (en) | CONTROL SECTION OF AN ENDOSCOPE, AND ENDOSCOPE | |
IL199807A (en) | Biometric diagnosis | |
ZA201202308B (en) | Device which permits slimming by improving blood flow in the abdomen area. | |
GB0901837D0 (en) | Cancer diagnosis and treatment | |
AP2012006302A0 (en) | Anti-trypanosome therapeutic and diagnostic applications. | |
AP2012006202A0 (en) | Cancer starvation therapy. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210518 |